Singapore markets closed

Rallybio Corporation (RLYB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7700-0.0900 (-4.84%)
At close: 04:00PM EDT
1.7700 0.00 (0.00%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 77.10M
Enterprise value -16.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.86
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.41

Trading information

Stock price history

Beta (5Y monthly) -1.63
52-week change 3-70.57%
S&P500 52-week change 326.36%
52-week high 39.1400
52-week low 31.2250
50-day moving average 31.7730
200-day moving average 32.9006

Share statistics

Avg vol (3-month) 31.6M
Avg vol (10-day) 3189.94k
Shares outstanding 541.45M
Implied shares outstanding 642.56M
Float 823.2M
% held by insiders 14.06%
% held by institutions 175.78%
Shares short (30 Apr 2024) 41.96M
Short ratio (30 Apr 2024) 40.47
Short % of float (30 Apr 2024) 46.62%
Short % of shares outstanding (30 Apr 2024) 44.72%
Shares short (prior month 28 Mar 2024) 41.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-36.80%
Return on equity (ttm)-62.43%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -76.9M
Net income avi to common (ttm)-76.28M
Diluted EPS (ttm)-1.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)94.17M
Total cash per share (mrq)2.27
Total debt (mrq)339k
Total debt/equity (mrq)0.38%
Current ratio (mrq)9.77
Book value per share (mrq)2.36

Cash flow statement

Operating cash flow (ttm)-56.96M
Levered free cash flow (ttm)-28.28M